METiS Therapeutics

About:

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

Website: https://www.metistx.com/

Twitter/X: MetisTx

Top Investors: Sequoia Capital China, Frees Fund, 5Y Capital, CMB International Capital Corporation, Lightspeed China Partners

Description:

METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Total Funding Amount:

$176M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

contact(AT)metistx.com

Founders:

Chris Lai

Number of Employees:

11-50

Last Funding Date:

2022-04-05

IPO Status:

Private

© 2024 MyAiNote.com